173 related articles for article (PubMed ID: 3996169)
21. A 10-yr follow-up study for the detection of peripheral neuropathy in young patients with type 1 diabetes.
Hajas G; Kissova V; Tirpakova A
Pediatr Diabetes; 2016 Dec; 17(8):632-641. PubMed ID: 27028140
[TBL] [Abstract][Full Text] [Related]
22. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy.
Reljanovic M; Reichel G; Rett K; Lobisch M; Schuette K; Möller W; Tritschler HJ; Mehnert H
Free Radic Res; 1999 Sep; 31(3):171-9. PubMed ID: 10499773
[TBL] [Abstract][Full Text] [Related]
23. Effect of glycemic control on electrophysiologic changes of diabetic neuropathy in type 2 diabetic patients.
Huang CC; Chen TW; Weng MC; Lee CL; Tseng HC; Huang MH
Kaohsiung J Med Sci; 2005 Jan; 21(1):15-21. PubMed ID: 15754584
[TBL] [Abstract][Full Text] [Related]
24. Peroneal motor nerve conduction velocity in diabetic children and adolescents. Relationships to metabolic control, HLA-DR antigens, retinopathy, and EEG.
Dorchy H; Noel P; Kruger M; de Maertelaer V; Dupont E; Toussaint D; Pelc S
Eur J Pediatr; 1985 Nov; 144(4):310-5. PubMed ID: 3865772
[TBL] [Abstract][Full Text] [Related]
25. Long-term effects of ranirestat (AS-3201) on peripheral nerve function in patients with diabetic sensorimotor polyneuropathy.
Bril V; Buchanan RA
Diabetes Care; 2006 Jan; 29(1):68-72. PubMed ID: 16373898
[TBL] [Abstract][Full Text] [Related]
26. Diabetic neuropathy 3 years after successful pancreas and kidney transplantation.
Müller-Felber W; Landgraf R; Scheuer R; Wagner S; Reimers CD; Nusser J; Abendroth D; Illner WD; Land W
Diabetes; 1993 Oct; 42(10):1482-6. PubMed ID: 8375588
[TBL] [Abstract][Full Text] [Related]
27. The prevalence of peripheral neuropathy in newly diagnosed patients with non-insulin-dependent diabetes mellitus.
Weerasuriya N; Siribaddana S; Wijeweera I; Dissanayeka A; Wijesekera J; Fernando DJ
Ceylon Med J; 1998 Mar; 43(1):19-21. PubMed ID: 9624839
[TBL] [Abstract][Full Text] [Related]
28. Early electrophysiological abnormalities and clinical neuropathy: a prospective study in patients with type 1 diabetes.
Hyllienmark L; Alstrand N; Jonsson B; Ludvigsson J; Cooray G; Wahlberg-Topp J
Diabetes Care; 2013 Oct; 36(10):3187-94. PubMed ID: 23723354
[TBL] [Abstract][Full Text] [Related]
29. Early diabetic complications in a population of young patients with type 1 diabetes mellitus despite intensive treatment.
Nordwall M; Hyllienmark L; Ludvigsson J
J Pediatr Endocrinol Metab; 2006 Jan; 19(1):45-54. PubMed ID: 16509528
[TBL] [Abstract][Full Text] [Related]
30. Glycemic control and nerve conduction abnormalities in non-insulin-dependent diabetic subjects.
Graf RJ; Halter JB; Pfeifer MA; Halar E; Brozovich F; Porte D
Ann Intern Med; 1981 Mar; 94(3):307-11. PubMed ID: 7013592
[TBL] [Abstract][Full Text] [Related]
31. Neuropathy in children and adolescents with diabetes mellitus.
Gallai V; Firenze C; Mazzotta G; Del Gatto F
Acta Neurol Scand; 1988 Aug; 78(2):136-40. PubMed ID: 2845698
[TBL] [Abstract][Full Text] [Related]
32. Presence of carpal tunnel syndrome in diabetics: effect of age, sex, diabetes duration and polyneuropathy.
Comi G; Lozza L; Galardi G; Ghilardi MF; Medaglini S; Canal N
Acta Diabetol Lat; 1985; 22(3):259-62. PubMed ID: 4072571
[TBL] [Abstract][Full Text] [Related]
33. Validity of the neurological examination in diagnosing diabetic peripheral neuropathy.
Höliner I; Haslinger V; Lütschg J; Müller G; Barbarini DS; Fussenegger J; Zanier U; Saely CH; Drexel H; Simma B
Pediatr Neurol; 2013 Sep; 49(3):171-7. PubMed ID: 23831248
[TBL] [Abstract][Full Text] [Related]
34. Nerve conduction in children suffering insulin dependent diabetes mellitus.
Cenesiz F; Tur BS; Tezic T; Gurer Y
Indian J Pediatr; 2003 Dec; 70(12):945-51. PubMed ID: 14719781
[TBL] [Abstract][Full Text] [Related]
35. Amelioration of nerve conduction velocity following simultaneous kidney/pancreas transplantation is due to the glycaemic control provided by the pancreas.
Martinenghi S; Comi G; Galardi G; Di Carlo V; Pozza G; Secchi A
Diabetologia; 1997 Sep; 40(9):1110-2. PubMed ID: 9300250
[TBL] [Abstract][Full Text] [Related]
36. Near-normoglycaemia and development of neuropathy: a 24-year prospective study from diagnosis of type 1 diabetes.
Ziegler D; Behler M; Schroers-Teuber M; Roden M
BMJ Open; 2015 Jun; 5(6):e006559. PubMed ID: 26109108
[TBL] [Abstract][Full Text] [Related]
37. Effects of exenatide on measures of diabetic neuropathy in subjects with type 2 diabetes: results from an 18-month proof-of-concept open-label randomized study.
Jaiswal M; Martin CL; Brown MB; Callaghan B; Albers JW; Feldman EL; Pop-Busui R
J Diabetes Complications; 2015; 29(8):1287-94. PubMed ID: 26264399
[TBL] [Abstract][Full Text] [Related]
38. Asymptomatic peripheral nerve dysfunction and vascular reactivity in IDDM patients with and without microalbuminuria.
Bodmer CW; Masson EA; Savage MW; Benbow S; Patrick AW; Williams G
Diabetologia; 1994 Oct; 37(10):1056-61. PubMed ID: 7851685
[TBL] [Abstract][Full Text] [Related]
39. Body sway in diabetic neuropathy.
Uccioli L; Giacomini PG; Monticone G; Magrini A; Durola L; Bruno E; Parisi L; Di Girolamo S; Menzinger G
Diabetes Care; 1995 Mar; 18(3):339-44. PubMed ID: 7555477
[TBL] [Abstract][Full Text] [Related]
40. Peripheral and autonomic nerve function in 259 diabetic patients with peripheral neuropathy treated with ponalrestat (an aldose reductase inhibitor) or placebo for 18 months. United Kingdom/Scandinavian Ponalrestat Trial.
Sundkvist G; Armstrong FM; Bradbury JE; Chaplin C; Ellis SH; Owens DR; Rosén I; Sönksen P
J Diabetes Complications; 1992; 6(2):123-30. PubMed ID: 1611136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
